Where is the product manufactured?

The place of origin is Hubei, China.

Canine Parvo & Corona Virus Rapid Test Kit

Name: Canine Parvo & Corona Virus Rapid Test Kit
Brand: Auker Biotech Co., Ltd.
SKU: 1973921091

Hubei, ChinaAuker Biotech Co., Ltd.

US$2.50

200-999 Pieces

US$2.30

1,000-4,999 Pieces

US$2.00

5,000+ Pieces

Product profile

Customization

Available

Type

IVD Reagent

place of origin

China

Model NO.

CPV/CCV

MOQ

20box

OEM/ODM

Available

delivery time

1-7days

payment method

T/T, paypal

Transport Package

10test/Box, 50box/Carton

Specification

10test/box

Trademark

sunpet

Origin

China

HS Code

3822190010

Production Capacity

100000/Month

Key features

Rapid Results: Provides qualitative results within 5-10 minutes using chromatographic immunoassay.

OEM/ODM Available: Customization services including branding and packaging are available for orders.

Flexible Delivery: Fast delivery time of 1-7 days from Hubei, China.

Easy Storage: Can be stored at temperatures between 4-30 degrees Celsius.

Clear Visual Readout: Positive results show a visible wine-red line; C line confirms test validity.

Multiple Packaging Options: Available in 1 Test/Kit or 10 Tests/Kit configurations.

Global Shipping: Shipped via FOB, EXW, or CIF terms to markets worldwide.

Company profile

Auker Biotech Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-04-30Nearest Port: Wuhan, ShanghaiAverage Response Time: ≤15hTerms of Payment: T/T, PayPal, Western UnionInternational Commercial Terms(Incoterms): FOB, EXW, CIF

AI-Powered supplier vetting

SummaryAuker Biotech Co., Ltd. is a China-based limited company and factory/trading company located in Wuhan, Hubei. It specializes in in-vitro diagnostic raw materials, including antigens, antibodies, recombinant proteins, and related customized services. The supplier reports ISO 9001 and ISO 13485 certifications, two technology platforms, three production lines, dedicated R&D and quality-control personnel, and export activity across multiple global regions. It has self-operated import/export rights and reports order fulfillment within 15 working days in both peak and off-peak periods. Evidence supports established technical, certification, production, and export capabilities. However, the provided information does not sufficiently establish after-sales service practices, financial credibility, or verified customer case depth. The trade record shows only two transactions and one associated buyer name, so customer experience evidence remains limited.

Supplier typeThe supplier is identified as a factory, manufacturer/trading company, and limited company based in Wuhan, China. Its stated business focuses on R&D, production, and sales of in-vitro diagnostic raw materials, including antigens, antibodies, and recombinant proteins.

CertificationsThe supplier reports ISO 9001 and ISO 13485 quality system certifications. These certifications provide explicit evidence of formal quality-management and medical-device-related management systems.

R&D capabilityThe company states that it was established in 2002, operates a mouse monoclonal antibody hybridoma platform and a recombinant protein expression platform, and is recognized as a high-tech enterprise with several innovation-related honors. These details explicitly support established R&D and innovation capability.

Production capacityThe supplier reports production of in-vitro diagnostic raw materials, three production lines, operation of a colloidal gold and fluorescence chromatography large-plate production line since 2021, and order fulfillment within 15 working days in both peak and off-peak seasons. This supports active and reasonably responsive production capability.

Customization capabilityThe company explicitly states that it provides customized services for monoclonal antibodies, multi-antibodies, and recombinant proteins. This is direct evidence of customization capability in its core product categories.